Page last updated: 2024-11-03

propranolol and Diabetic Cardiomyopathies

propranolol has been researched along with Diabetic Cardiomyopathies in 2 studies

Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.

Diabetic Cardiomyopathies: Diabetes complications in which VENTRICULAR REMODELING in the absence of CORONARY ATHEROSCLEROSIS and hypertension results in cardiac dysfunctions, typically LEFT VENTRICULAR DYSFUNCTION. The changes also result in myocardial hypertrophy, myocardial necrosis and fibrosis, and collagen deposition due to impaired glucose tolerance.

Research Excerpts

ExcerptRelevanceReference
"Propranolol treatment normalized also the prolongation of the action potential in papillary muscles from the diabetic rat hearts."1.37Cardioprotective effect of propranolol on diabetes-induced altered intracellular Ca2+ signaling in rat. ( Tuncay, E; Turan, B; Zeydanli, EN, 2011)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jungen, C1
Scherschel, K1
Flenner, F1
Jee, H1
Rajendran, P1
De Jong, KA1
Nikolaev, V1
Meyer, C1
Ardell, JL1
Tompkins, JD1
Tuncay, E1
Zeydanli, EN1
Turan, B1

Other Studies

2 other studies available for propranolol and Diabetic Cardiomyopathies

ArticleYear
Increased arrhythmia susceptibility in type 2 diabetic mice related to dysregulation of ventricular sympathetic innervation.
    American journal of physiology. Heart and circulatory physiology, 2019, 12-01, Volume: 317, Issue:6

    Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Calcium Signaling; Diabetic Cardiomyopathies;

2019
Cardioprotective effect of propranolol on diabetes-induced altered intracellular Ca2+ signaling in rat.
    Journal of bioenergetics and biomembranes, 2011, Volume: 43, Issue:6

    Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Antibiotics, Antineoplastic; Calcium Signaling;

2011
chemdatabank.com